Ratio Examination: Pyxis Oncology Inc (PYXS)’s Price-to-Cash and Price-to-Free Cash Flow

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

In the latest session, Pyxis Oncology Inc (NASDAQ: PYXS) closed at $4.20 down -2.10% from its previous closing price of $4.29. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 0.54 million shares were traded. PYXS stock price reached its highest trading level at $4.33 during the session, while it also had its lowest trading level at $4.01.

Ratios:

For a deeper understanding of Pyxis Oncology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 12.19. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.

On February 09, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $8.

On January 23, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $12.Leerink Partners initiated its Outperform rating on January 23, 2024, with a $12 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 28 ’23 when Connealy Pamela Ann bought 8,000 shares for $1.87 per share. The transaction valued at 14,960 led to the insider holds 818,532 shares of the business.

Connealy Pamela Ann bought 6,426 shares of PYXS for $11,868 on Sep 27 ’23. The CFO and COO now owns 810,532 shares after completing the transaction at $1.85 per share. On Sep 27 ’23, another insider, Wadhane Jitendra, who serves as the Chief Accounting Officer of the company, bought 2,500 shares for $1.87 each. As a result, the insider paid 4,675 and bolstered with 226,937 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PYXS now has a Market Capitalization of 252579584 and an Enterprise Value of 146193168. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.31 while its Price-to-Book (P/B) ratio in mrq is 1.34.

Stock Price History:

Over the past 52 weeks, PYXS has reached a high of $6.85, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is -13.90%, while the 200-Day Moving Average is calculated to be 37.80%.

Shares Statistics:

For the past three months, PYXS has traded an average of 733.05K shares per day and 462220 over the past ten days. A total of 58.88M shares are outstanding, with a floating share count of 46.86M. Insiders hold about 20.40% of the company’s shares, while institutions hold 33.80% stake in the company. Shares short for PYXS as of 1714435200 were 1849743 with a Short Ratio of 2.52, compared to 1711584000 on 2702190. Therefore, it implies a Short% of Shares Outstanding of 1849743 and a Short% of Float of 3.94.

Most Popular

[the_ad id="945"]